BME shows a wide margin of safety and best-in-class margins within a wide-moat, compounding business, but earnings quality warnings, a Rule of 40 failure, and an overbought setup near a 52-week high leave upside already exhausted by the engine's own gates.
Thesis pillars
- Earnings Quality Red Flag Despite Moat→Stable
- Margin Of Safety And Attractive Valuation→Stable
- Near 52 Week High Upside Exhausted→Stable
- +2 more pillars — see the Why tab for full reasoning
Blackrock Health Sciences Trust (BME) Stock Analysis
Range Bound setup · Inst Constrain edge
Financial Services · Asset Management
Hold if already holding. Not a fresh buy at $42.85, but acceptable to hold if already in. Reason: Near 52-week high (3.4% away).
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health... Read more
Hold if already holding. Not a fresh buy at $42.85, but acceptable to hold if already in. Reason: Near 52-week high (3.4% away). Chart setup: RSI 44 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Score 6.2/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 ceiling hits
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $42.85, but acceptable to hold if already in. Reason: Near 52-week high (3.4% away). Chart setup: RSI 44 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Target $43.20 (+0.8%), stop $41.61 (−3.0%), A.R:R 0.0:1. Score 6.2/10, moderate confidence.
Take-profit target: $43.20 (+0.8% upside). Target $43.20 (+0.8%), stop $41.61 (−3.0%), A.R:R 0.0:1. Stop-loss: $41.61.
Near 52-week high (3.4% away).
Blackrock Health Sciences Trust trades at a P/E of 7.2 (forward N/A). TrendMatrix value score: 9.6/10. Verdict: Hold.
What does Blackrock Health Sciences Trust do?BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by...
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.